Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM).

被引：6
|
作者：
Lokhorst, Henk M.
Laubach, Jacob
Nahi, Hareth
Plesner, Torben
Gimsing, Peter
Hansson, Markus
Minnema, Monique
Lassen, Ulrik Niels
Krejcik, Jakub
Ahmadi, Tahamtan
Lisby, Steen
Basse, Linda
Brun, Nikolai C.
Richardson, Paul G.
机构：
[1] UMC Utrecht, Utrecht, Netherlands
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Karolinska Univ Sjukhuset Huddinge, Huddinge, Sweden
[4] Vejle Hosp, Vejle, Denmark
[5] Copenhagen Univ Hosp, Copenhagen, Denmark
[6] Skane Univ Hosp, Lund, Sweden
[7] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark
[8] Janssen Res & Dev, Spring House, PA USA
[9] Genmab AS, Copenhagen, Denmark
[10] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8513
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of daratumumab in Japanese patients with relapsed or refractory multiple myeloma: a multicenter, phase 1, dose-escalation study
    Shinsuke Iida
    Kenshi Suzuki
    Shigeru Kusumoto
    Masaki Ri
    Nobuhiro Tsukada
    Yu Abe
    Masayuki Aoki
    Mitsuo Inagaki
    International Journal of Hematology, 2017, 106 : 541 - 551
  • [42] Safety and efficacy of daratumumab in Japanese patients with relapsed or refractory multiple myeloma: a multicenter, phase 1, dose-escalation study
    Iida, Shinsuke
    Suzuki, Kenshi
    Kusumoto, Shigeru
    Ri, Masaki
    Tsukada, Nobuhiro
    Abe, Yu
    Aoki, Masayuki
    Inagaki, Mitsuo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 541 - 551
  • [43] Phase II study of daratumumab (DARA) monotherapy in patients with ≥ 3 lines of prior therapy or double refractory multiple myeloma (MM): 54767414MMY2002 (Sirius).
    Lonial, Sagar
    Weiss, Brendan M.
    Usmani, Saad Zafar
    Singhal, Seema
    Chari, Ajai
    Bahlis, Nizar J.
    Belch, Andrew
    Krishnan, Amrita Y.
    Vescio, Robert A.
    Mateos, Mara-Victoria
    Mazumder, Amitabha
    Orlowski, Robert Z.
    Sutherland, Heather J.
    Blade, Joan
    Scott, Emma Catherine
    Feng, Huaibao
    Khan, Imran
    Uhlar, Clarissa M.
    Ahmadi, Tahamtan
    Voorhees, Peter Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Phase II study of daratumumab (DARA) monotherapy in patients with ≥ 3 lines of prior therapy or double refractory multiple myeloma (MM): 54767414MMY2002 (Sirius)
    Lonial, Sagar
    Weiss, Brendan M.
    Usmani, Saad Zafar
    Singhal, Seema
    Chari, Ajai
    Bahlis, Nizar J.
    Belch, Andrew
    Krishnan, Amrita Y.
    Vescio, Robert A.
    Mateos, Maria-Victoria
    Mazumder, Amitabha
    Orlowski, Robert Z.
    Sutherland, Heather J.
    Blade, Joan
    Scott, Emma Catherine
    Feng, Huaibao
    Khan, Imran
    Uhlar, Clarissa M.
    Ahmadi, Tahamtan
    Voorhees, Peter Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18)
  • [45] Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma
    Shackleton, Louisa
    Fay, James
    Smyth, Elizabeth
    Murphy, Philip
    Glavey, Siobhan
    Quinn, John
    EJHAEM, 2020, 1 (01): : 312 - 314
  • [46] Clinical Efficacy of Daratumumab, Pomalidomide and Dexamethasone in Relapsed, Refractory Myeloma Patients: Utility of Retreatment with Daratumumab Among Refractory Patients
    Nooka, Ajay K.
    Joseph, Nisha
    Boise, Larry H.
    Gleason, Charise
    Kaufman, Jonathan L.
    Lonial, Sagar
    BLOOD, 2016, 128 (22)
  • [47] DARATUMUMAB IN MONOTHERAPY AND COMBINATION AS TREATMENT IN RELAPSED / REFRACTORY MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL HOSPITAL
    Auria Caballero, C.
    Gamarro Calvo, S.
    De Poo Rodriguez, M., V
    Martinez Fernandez, R.
    Sanchez Quinones, B.
    Dourdil Sahun, M., V
    Bonafonte Arruga, E.
    Alcacera Lopez, A.
    Palomera Bernal, L.
    HAEMATOLOGICA, 2018, 103 : 124 - 124
  • [48] Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Nahi, Hareth
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Chari, Ajai
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    Hellemans, Peter
    Masterson, Tara
    Clemens, Pamela L.
    Luo, Man
    Liu, Kevin
    San-Miguel, Jesus
    BLOOD, 2019, 134 (08) : 668 - 677
  • [49] Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma
    Hannah A. Blair
    Drugs, 2018, 78 : 397 - 397
  • [50] Real-world outcomes of daratumumab monotherapy in relapsed/refractory myeloma
    Maouche, N.
    Leary, H.
    Collings, F.
    Tseu, B.
    Djebbari, F.
    Vallance, G.
    Ramasamy, K.
    Kothari, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 125 - 125
12345